CARsgen's Series A Round

CARsgen raised a round of funding on November 26, 2014. Investors include BVCF.

CARsgen (科济生物) is an immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has r…

Articles about CARsgen's Series A Round: